Abstract: A vehicle controller includes: an engine controller configured to perform an IS control upon satisfaction of a predetermined stop condition and an engine restart control upon satisfaction of a predetermined restart condition; an HDC controller configured to perform, when the vehicle is traveling on a downhill road and a deceleration request according to an HDC control occurs, a target vehicle speed-based deceleration irrespective of brake operations by the driver; and an information acquisition part configured to acquire progress status information related to the engine restart control and including information on initiation and completion thereof.

Abstract: A stator core is configured by assembling divided cores in an annular shape. Each core includes a yoke part extending in a circumferential direction, and having opposite first and second facing sections. The first facing section includes an inner circumferential protrusion, an outer circumferential protrusion, and a central recess. The second facing section includes an inner circumferential notch, an outer circumferential notch, and a central protrusion. When the cores are assembled, the inner circumferential protrusion faces the inner circumferential notch, the outer circumferential protrusion faces the outer circumferential notch, and the central recess faces the central protrusion, and the outer circumferential protrusion is formed so as to have a width larger in a direction orthogonal to a circumference direction than that of the inner circumferential protrusion.

Abstract: Provided is a structure including a sound absorption section provided in an air flow path on an exhaust side of a fan, traversing a joint portion between a first main housing and a second main housing. The sound absorption section has a double wall structure including an inner wall facing the air flow path and an outer wall spaced outward from the inner wall. A sound absorption member is interposed in a sound absorption chamber between the inner wall and the outer wall of the sound absorption section. A communication hole communicating with the air flow path and the sound absorption chamber is formed in the inner wall of the sound absorption section at a position away from the joint portion.

Abstract: A stator core is configured by assembling divided cores in an annular shape. Each core includes a yoke part extending in a circumferential direction, and having opposite first and second facing sections. The first facing section includes an inner circumferential protrusion, an outer circumferential protrusion, and a central recess. The second facing section includes an inner circumferential notch, an outer circumferential notch, and a central protrusion. When the cores are assembled, the inner circumferential protrusion faces the inner circumferential notch, the outer circumferential protrusion faces the outer circumferential notch, and the central recess faces the central protrusion, and the outer circumferential protrusion is formed so as to have a width larger in a direction orthogonal to a circumference direction than that of the inner circumferential protrusion.

Abstract: Provided is a structure including a sound absorption section provided in an air flow path on an exhaust side of a fan, traversing a joint portion between a first main housing and a second main housing. The sound absorption section has a double wall structure including an inner wall facing the air flow path and an outer wall spaced outward from the inner wall. A sound absorption member is interposed in a sound absorption chamber between the inner wall and the outer wall of the sound absorption section. A communication hole communicating with the air flow path and the sound absorption chamber is formed in the inner wall of the sound absorption section at a position away from the joint portion.

Abstract: The present invention provides a method for purifying an amino acid contained in an aqueous solution of alkali metal salt of amino acid comprising the steps of: (1) cation exchanging, which comprises subjecting an aqueous solution of alkali metal salt of amino acid to a desalting purification treatment using a moving bed type continuous ion exchange apparatus comprising a cation exchange resin to obtain an aqueous solution of crude amino acid; and (2) anion exchanging, which comprises adsorbing to a weakly basic anion exchange resin an iminodicarboxylic acid, which is a coexisting by-product, in the resulting aqueous solution of crude amino acid to remove the iminodicarboxylic acid, wherein the aqueous solution of crude amino acid is passed even after adsorbing the iminodicarboxylic acid to the break through point of the weakly basic anion exchange resin.

Abstract: The present invention provides a method for purifying an amino acid contained in an aqueous solution of alkali metal salt of amino acid comprising the steps of: (1) cation exchanging, which comprises subjecting an aqueous solution of alkali metal salt of amino acid to a desalting purification treatment using a moving bed type continuous ion exchange apparatus comprising a cation exchange resin to obtain an aqueous solution of crude amino acid; and (2) anion exchanging, which comprises adsorbing to a weakly basic anion exchange resin an iminodicarboxylic acid, which is a coexisting by-product, in the resulting aqueous solution of crude amino acid to remove the iminodicarboxylic acid, wherein the aqueous solution of crude amino acid is passed even after adsorbing the iminodicarboxylic acid to the break through point of the weakly basic anion exchange resin.

Abstract: According to the present invention, fused imidazole derivatives of the general formula: 1

Abstract: A pyridazinone or pyridone compound of the following formula (I).

Abstract: Benzodiazepine derivatives of the formula: 1

Abstract: Benzodiazepine derivatives of the formula: 1

Abstract: Benzodiazepine derivatives of the formula: wherein R2 is alkyl or cycloalkyl-alkyl when R4 is hydrogen, or R2 is a variety of specified groups when R4 is alkyl, halogen or dialkylamino, are useful as cholecystokinin antagonists.

Abstract: Benzodiazepine derivatives of formula (I) wherein R.sup.1 is aryl which may have one or more suitable substituent(s), R.sup.2 is C.sub.3 -C.sub.8 cycloalkyl which may have one or more suitable substituent(s), A is lower alkylene, R.sup.3 is a heterocyclic group selected from the group consisting of tetrahydrofuryl, dioxolanyl, filryl, thienyl, isoxazolyl, pyridyl, benzimidazolyl, benzotiazolyl, benzoxazolyl, benzopyrany, quinolyl, isoquinolyl, tetrahydroisoquinolyl, benzothienyl and benzofuryl, each of which may have one or more suitable substituent(s), or a pharmaceutically acceptable salt thereof, which are useful as a medicament.

Abstract: The invention relates to novel cholecystokinin antagonists of the formula ##STR1## wherein R.sup.1 is aryl or substituted aryl, and a pharmaceutically acceptable salt thereof useful as cholecystokinin antagonists.

Abstract: The invention relates to a compound of the formula ##STR1## wherein R.sup.1 is aryl which may have suitable substituent(s), X is --O-- or ##STR2## in which R.sup.3 is hydrogen or lower alkyl, A is a bond or lower alkylene which may have lower alkyl group(s), andR.sup.2 is arylcarbamoyl which may have halogen or lower alkoxy,or a pharmaceutically acceptable salt thereof, useful as a cholecystokinin antagonist.

Abstract: Intermediates of the formula: ##STR1## wherein R.sup.1 is tetrazolyl or imidazolyl, each of which may have an imino protective group,R.sup.2 is phenyl which may have a halogen atom,R.sup.3 is hydrogen or halogen, andA is lower alkylene, or a salt thereof.They are useful in the preparation of benzodiazepine derivatives and pharmaceutically acceptable salts thereof which are cholecystokinin (CCK) antagonists and therefore can be used as therapeutical agents for emesis, pancreatitis, satiety and appetite control, pain control, insulinoma, gastroparesis, acute obstructive cholecystitis, irritable bowel disease and carcinoma of pancreas.

Abstract: Tricyclic compounds of the formula: ##STR1## wherein R.sup.1 1 is hydrogen or an organic group,R.sup.2 is aryl which may have suitable substituent(s),R.sup.3 is hydrogen or an acyl group andA is lower alkylene,and pharmaceutically acceptable salts thereof which are useful as a medicament.

Abstract: A compound of the formula ##STR1## the process for its preparation and intermediate thereof. The compound is useful as a cholecystokinin antagonist.

Abstract: The invention relates to novel cholecystokinin antagonists of the formula ##STR1## wherein R.sup.1 is aryl which may have suitable substituent(s), X is --O-- or ##STR2## in which R.sup.3 is hydrogen or lower alkyl, A is bond; or methylene, ethylene, trimethylene, tetramethylene, pentamethylene or hexamethylene, each of which may have lower alkyl group(s), andR.sup.2 is heterocyclic(C.sub.3 -C.sub.6) alkenoyl or heterocycliciccarbonyl, or a pharmaceutically acceptable salt thereof, useful as a cholecystokinin antagonist.

Abstract: The invention relates to a compound of the formula: ##STR1## wherein R.sup.1 is aryl which may have suitable substituents(s), X is --O-- or ##STR2## in which R.sup.3 is hydrogen or lower alkyl, A is a bond or lower alkylene which may have lower alkyl group(s), andR.sup.2 is hydrogen; heterocyclic(lower)alkenoyl which may have carboxy or protected carboxy; heterocycliccarbonyl which may have N,N-di(lower)alkylamino(lower)alkyl, hydroxyimino(lower)alkyl, aryliminio(lower)alkyl, acyl or hydroxy(lower)alkylheterocyclic(lower)alkyl; aroyl which may have 1 to 3 substituent(s) selected from the group consisting of halogen, amino and mono(or di or tri)halo(lower)alkyl; arylcarbamoyl which may have halogen or lower alkoxy; arylamino(lower)alkanoyl; or ar(lower)alkanoyl which may have amino or protected amino,or a pharmaceutically acceptable salt thereof, useful as a cholecystokinin antagonist.